Pharmacodynamics & Pharmacokinetics: Pharmacodynamics & Pharmacokinetics: PI and PIL considerations PI and PIL considerations Douglas W Oliver School of Pharmacy / Unit for Drug Research & Development SAAPRA 16 November 2012
Pharmacodynamics & Pharmacokinetics: PI and PIL considerations
Feb 13, 2016
Pharmacodynamics & Pharmacokinetics: PI and PIL considerations. Douglas W Oliver School of Pharmacy / Unit for Drug Research & Development. SAAPRA 16 November 2012. Presentation. Introduction: Drug Discovery Research Background: PK/PD Pharmacodynamics (CTD Modules 4&5) Pharmacokinetics - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Pharmacodynamics & Pharmacokinetics:Pharmacodynamics & Pharmacokinetics:PI and PIL considerationsPI and PIL considerations
Douglas W OliverSchool of Pharmacy / Unit for Drug Research &
Development
SAAPRA 16 November 2012
Presentation
• Introduction: – Drug Discovery Research
• Background: PK/PD• Pharmacodynamics
– (CTD Modules 4&5)• Pharmacokinetics
– (CTD Modules 4&5)• Specific Considerations• MCC
– Regulatory Framework• Additional Information• Conclusion
INTRODUCTION AND
BACKGROUND
The human
4
Related Documents
